May 2021 edition : Leading Better Value Care
The Agency for Clinical Innovation is conducting a formative evaluation and revising the economic appraisal of the Leading Better Value Care (LBVC) Bronchiolitis initiative. This is due for completion in June 2021.
The evaluation aims to understand to what extent the initiative has been implemented so far across NSW to inform next steps.
The evaluation is a mixed methods evaluation and includes analysis of data from the following sources: statewide routine administrative data, patient (carer) experience surveys, online implementation review tool, in depth interviews and acute review clinic economic case studies.
The evaluation and revised economic appraisal includes analysis and reporting on:
The Agency for Clinical Innovation has been working with the Ministry of Health to scope the following evaluations on LBVC initiatives:
This scoping work provides guidance on these future evaluations including: